PRA Health Sciences Dividenda 2025

Co dělá PRA Health Sciences?

PRA Health Sciences Inc. is a globally operating company for clinical research that was founded in 1982 and is headquartered in Raleigh, North Carolina. It specializes in supporting pharmaceutical and medical device manufacturers in the development and approval of drugs and medical devices. The business model of PRA Health Sciences is based on providing services throughout the entire clinical development process. This includes planning and conducting clinical trials, monitoring study centers, data collection and management, as well as statistics and medical consulting. The company's activities are divided into several divisions that focus on different areas of clinical development. The "Early Development Services" division offers services for the early clinical development of drugs and medical devices, including the conduct of Phase I studies and support for proof-of-concept studies. The "Clinical Development Services" division offers services for the later clinical development of drugs and medical devices, including the conduct of Phase II to Phase IV studies. The "Strategic Solutions" division offers a wide range of services for the entire clinical development process, including consulting, data analysis and interpretation, as well as the integration of technologies such as electronic medical records software. The "Product Registration" division offers services for the approval of drugs and medical devices, including support for submission of applications and the provision of regulatory affairs consulting services. One of the products offered by PRA Health Sciences is the "Lifetree Clinical Research" software platform, which is used for the management of clinical trials. Lifetree offers features for data management, project collaboration, and reporting, allowing users to access extensive amounts of data in real-time. PRA Health Sciences has a broad customer base including pharmaceutical and biotech companies, medical device manufacturers, and contract research organizations. The company has offices in more than 80 countries and employs approximately 18,000 people worldwide. In 2020, PRA Health Sciences was acquired by ICON plc, another globally operating company for clinical research. The acquisition is intended to expand ICON's global presence and service areas, enabling the company to offer a broader range of services in clinical development to its clients. Overall, PRA Health Sciences is a company for clinical research that offers a wide range of services for the development of drugs and medical devices. With its broad customer base, comprehensive range of services, and global presence, it is an important component of the clinical research industry and is expected to continue to play a crucial role in the development of new drugs and medical devices. PRA Health Sciences je jednou z nejoblíbenějších společností na Eulerpool.com.